Other side effects:
Very common(may affect more than 1 in 10 people): headache.
Common(may affect up to 1 in 10 people): nausea, facial flushing, warmth (including symptoms such as sudden heat sensation in the upper body), indigestion, abnormal color perception, blurred vision, visual deterioration, nasal congestion, and dizziness.
Uncommon(may affect up to 1 in 100 people): vomiting, skin rash, watery eyes, eye irritation, eye discharge/red eyes, eye pain, flashing lights, visual clarity, light sensitivity, rapid heartbeat, high blood pressure, low blood pressure, muscle pain, feeling of drowsiness, reduced tactile sensation, vertigo, tinnitus, dry mouth, nasal congestion or blockage, nasal mucosa inflammation (including symptoms such as sneezing, runny nose, and nasal congestion), upper abdominal pain, gastroesophageal reflux disease (including symptoms such as stomach burning), blood in the urine, arm or leg pain, nasal bleeding, feeling of heat, and feeling tired.
Rare(may affect up to 1 in 1,000 people): fainting, stroke, heart attack, irregular heartbeat, transient decrease in blood flow to some parts of the brain, sensation of throat constriction, numbness of the mouth, bleeding in the back of the eye, double vision, visual acuity decrease, abnormal sensation in the eye, eye swelling or eyelid swelling, small particles or spots in the vision, halos around lights, pupil dilation, change in color of the white part of the eye, penile bleeding, blood in semen, dry nose, nasal interior swelling, feeling of irritability, and sudden hearing loss.
The rarely reported side effects from post-marketing experience include: unstable angina (heart disease) and sudden death. Most, but not all, had heart problems before taking this medicine. It is not possible to determine if these events were directly related to Dragul.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use, Website:www.notificaRAM.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of sight and reach of children.
Store in the original packaging to protect it from moisture.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or trash. Dispose of packaging and unused medicines at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medicines. By doing so, you will help protect the environment.
Composition of Dragul 25 mg
Core tablet:microcrystalline cellulose, dibasic calcium phosphate, sodium croscarmellose, and magnesium stearate.
Coating:polyvinyl alcohol, polyethylene glycol 3350, titanium dioxide (E171), talc, and aluminum lake of indigo carmine.
Appearance of the product and contents of the packaging
Dragul 25 mg tablets have a coating, are elliptical in shape, and are blue in color. They are engraved with “-” on one face.
Dragul is presented in blisters of 4 tablets per packaging.
Only some packaging sizes may be commercially marketed.
Other presentations:
Dragul 50 mg, packaging of 1, 2, 4, or 8 tablets.
Dragul 100 mg, packaging with 4 or 8 tablets.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Biowise Pharmaceuticals, S.L.
C/Teixidors 22,
Polígono Can Rubiol
07141-Marratxí
Illes Balears
Responsible manufacturer:
ATLANTIC PHARMA -S.A. PRODUÇOES FARMACEUTICAS, S.A.
Rua da Tapada Grande, No 2
Abrunheira, Sintra - Portugal
Last review date of this leaflet:February2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.